Correction: van Veelen et al. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DEBuT-LRP Study. J. Clin. Med. 2023, 12, 5807
Anna van Veelen, I. Tarik Küçük, Federico H. Fuentes, Yirga Kahsay, Hector M. Garcia-Garcia, Ronak Delewi, Marcel A. M. Beijk, Alexander W. den Hartog, Maik J. Grundeken, M. Marije Vis, José P. S. Henriques, Bimmer E. P. M. Claessen

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsLipoproteins and Cardiovascular Health · Coronary Interventions and Diagnostics · Biosimilars and Bioanalytical Methods
1. Text Correction
In the original publication [1], there was a mistake in Section 2.8. Statistical Considerations, Paragraph 1. The corrected version of Section 2.8. Statistical Considerations, Paragraph 1 appears below:
Continuous baseline demographic and clinical variables will be presented in terms of percentiles (e.g., median, 25th, and 75th percentile or mean with standard deviation), while categorical variables are summarized in terms of frequencies and percentages. All p-values will be two-sided and a p-value of <0.05 will be considered statistically significant. The primary endpoint will be core-lab adjudicated and analyzed on both the lesion-level and the patient-level using a paired samples test. Missing data will be excluded from the analysis. The secondary endpoints will be summarized in frequencies and percentages.
2. Error in Table
In the original publication [1], there was a mistake in Table 3, as published. The corrected version of Table 3 appears below.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1van Veelen A. Küçük I.T. Fuentes F.H. Kahsay Y. García-García H.M. Delewi R. Beijk M.A.M. Den Hartog A.W. Grundeken M.J. Vis M.M. First-in-Human Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: Rationale and Design of the DE Bu T-LRP Study J. Clin. Med.202312580710.3390/jcm 1218580737762747 PMC 10531515 · doi ↗ · pubmed ↗
